tgoop.com/icgcs/474
Last Update:
🔹Key Speaker of CGC2024
🔸Dr. Vahid Khoddami
Vahid Khoddami is the founder and CEO of ReNAP Therapeutics. Khoddami received his BSc in Medical laboratory sciences from Tehran University of Medical Sciences, his MSc in medical biotechnology from Tarbiat Modarres University and his PhD in Oncological Sciences from University of Utah (Cairns lab; HHMI, Department of Oncological Sciences). He then served as postdoctoral fellow for one year at the Huntsman Cancer Institute, Utah, then moved to Boston to spend three more years as postdoctoral fellow at Harvard Medical School (Moazed lab; HHMI, Department of Cell Biology). Eventually following ten years of study and research in United States, in the field of epigenomics and epitrascriptomics with emphasis on RNA modification studies, Khoddami returned to Iran in 2017, and in 2019 he founded ReNAP Therapeutics, a leading company in the field of mRNA technology in Iran and the region.
🌐 WWW.ICGCS.COM
🔺 T.me/icgcs
🔺 instagram.com/icgcs
BY CGC2024
Share with your friend now:
tgoop.com/icgcs/474